Jonah Dallas Yakel alias The Brain Reversal Chiro
Website · drjonahyakel.com
Practice location
11791 W 112TH ST
OVERLAND PARK, KS 66210
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 14 health claims, 5 run counter to or conflict with the published evidence, and 9 were not independently checked.
- Primary persuasion tactic: MRI doom story sells the protocol.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Jonah Yakel is serving premium brain-fog redemption with a chiropractic side badge and a heroic mold-illness origin story. He doesn’t just promise healing — he promises to out-neurology the neurologists, out-immunize the immunologists, and do it all through a 'personalized program' that mysteriously sounds very consultable.
High grift signals
Score breakdown
Direct answer
Jonah Dallas Yakel is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. 65-2912(a)(6)-(7) (analogous scope/discipline limits for non‑physician providers)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Anxiety and depression, Autoimmune conditions, Mold and Lyme related illness, healing from CIRS, and CIRS+, conditions that belong with infectious-disease physicians, rheumatologists, and allergy and immunology specialists. Those same pages route patients toward supplements and paid programs that Jonah Dallas Yakel profits from.
Key findings
- Fear Mongering: He frames a terrifying prognosis to create urgency and make his later healing protocol feel lifesaving, even though the underlying claim about reversing severe degeneration is not established by mainstream evidence.see section ↓
- Claim "Cognitive decline, dementia, and Alzheimer's disease": mixed in the medical literature.see section ↓
- Claim "Anxiety and depression": mixed in the medical literature.see section ↓
- NPI registry confirms Jonah Yakel as Chiropractor (DC) in Kansas (NPI 1619145026).see section ↓
- Jonah Dallas Yakel shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Jonah Dallas Yakel is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. 65-2912(a)(6)-(7) (analogous scope/discipline limits for non‑physician providers)), these advertised activities appear outside Jonah Dallas Yakel's license (including conditions they merely list as ones they treat):…see section ↓
- 21 of 24 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
16 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Cognitive decline, dementia, and Alzheimer's disease as within their scope of practice.
Cognitive decline, dementia, and Alzheimer's disease
- Supports
- High-quality evidence shows that dementia, Alzheimer’s disease, and broader cognitive decline are common clinical entities with identifiable risk factors and modifiable influences, which supports the general claim that these conditions are real, prevalent, and affected by multiple domains of health. A Cochrane-systematic-review-level paper on multidomain interventions for dementia prevention reports that combined lifestyle and risk-factor management (diet, physical activity, cognitive training, vascular risk control) can produce small but statistically significant improvements in cognitive function in older adults at risk, though effects on incident dementia are limited, supporting the idea that cognitive decline and dementia are modifiable to a degree. [4] A systematic review and meta-analysis on diabetes medications finds that certain antidiabetic drugs (especially GLP‑1 receptor agonists and thiazolidinediones) are associated with reduced future dementia risk, indicating that metabolic health and pharmacologic management can influence dementia and cognitive decline outcomes. [1][3] Another systematic review of multidomain lifestyle interventions concludes that two‑thirds of included trials show improvement in cognition in older adults at risk of dementia when interventions target diet, physical activity, and cognitive training, suggesting that cognitive decline can be slowed or partially prevented in at‑risk populations. Systematic reviews of renal dysfunction and cognitive outcomes suggest that albuminuria and other kidney indicators are associated with an increased risk of cognitive impairment and dementia, supporting the concept of a brain–kidney axis where systemic disease contributes to neurodegeneration. [2]
- Contradicts
- The indexed evidence does not contradict the existence or clinical importance of cognitive decline, dementia, or Alzheimer’s disease; rather, it shows that while these are major public health problems, the effectiveness of preventive or therapeutic strategies is often modest and inconsistent. [5][6][7][8][9][10][11][12] The Cochrane-level multidomain intervention review reports no clear reduction in incident dementia despite small improvements in cognitive scores, indicating that current lifestyle-based prevention strategies have limited proven capacity to prevent dementia itself, and evidence is heterogeneous and sometimes at risk of bias. [1][4] Systematic reviews of antidiabetic drugs show protective associations for some agents but inconsistent or neutral findings for others, and many data come from observational studies with potential confounding, meaning that drug effects on dementia risk are not uniformly strong and causality is not fully established. [3] Brain–kidney axis evidence from renal dysfunction meta-analyses shows associations with dementia risk, but authors emphasize that the evidence base still needs strengthening, suggesting that mechanistic and interventional data are not yet robust enough to support strong claims about reversing or definitively preventing cognitive decline through kidney-focused interventions alone. [2]
- Mainstream view
- The mainstream medical and scientific position is that cognitive decline, dementia, and Alzheimer’s disease are common, clinically well‑defined conditions caused by complex interactions of neurodegenerative pathology, vascular factors, metabolic and systemic disease, and life‑course exposures, and that they represent major global health burdens. [4] Current consensus is that no single intervention can reliably prevent Alzheimer’s disease or dementia, but multidomain strategies—addressing cardiovascular and metabolic risk, physical activity, diet, cognitive and social engagement, hearing/vision management, and appropriate medications—can modestly improve cognitive trajectories and may delay onset in some high‑risk individuals. [2][3] Pharmacologic approaches (including selected diabetes medications) and risk-factor modification are regarded as promising adjuncts, yet guidelines generally frame these as risk-reduction strategies with partial, not curative, effects, and emphasize that evidence remains mixed and evolving. [1]
“Cognitive decline, dementia, and Alzheimer's disease”
Rule: K.S.A. 65-2912(a)(6)-(7) (analogous scope/discipline limits for non‑physician providers)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Anxiety and depression.
Anxiety and depression
- Supports
- The influencer’s claim is extremely vague (“Anxiety and depression”) and does not specify any particular mechanism or treatment, but there is extensive high‑quality evidence that anxiety disorders and depressive disorders are common, clinically significant conditions with effective treatments. [13] Systematic reviews and major guidelines consistently support that structured psychological interventions, especially cognitive behavioral therapy (CBT), are effective for both anxiety and depression across diverse populations, including primary care patients, those with chronic medical illness, and university students, with small to large effect sizes on symptom reduction. [20] Large practice guidelines from WHO, national psychiatric associations, and evidence-informed clinical practice guidelines recommend CBT and related structured psychotherapies as first-line treatments for generalized anxiety disorder, panic disorder, and mild to moderate major depressive disorder, and as key components of care for more severe depression, often in combination with antidepressant medication. [14][15][16][17][18][19] Systematic metareviews and guideline summaries show that selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have robust evidence from randomized controlled trials and meta-analyses for reducing symptoms in generalized anxiety disorder and major depressive disorder, particularly when functional impairment is marked, and that combining pharmacotherapy with psychotherapy improves outcomes compared with either alone. Multiple systematic reviews and meta-analyses demonstrate benefit from additional or adjunctive interventions (e. g. , breathing exercises, physical exercise, collaborative care models, neurofeedback, saffron supplementation) for anxiety and depression in specific populations, although these are generally regarded as adjuncts rather than primary treatments. Overall, mainstream high‑quality evidence strongly supports that anxiety and depression are treatable medical conditions and that structured psychotherapy and, where appropriate, antidepressant pharmacotherapy provide clinically meaningful improvement.
- Contradicts
- Because the influencer’s claim is not specific, there is no single discrete statement to be contradicted, but high‑quality evidence does contradict several common misinformation themes around anxiety and depression. [14][17] Major guidelines and systematic reviews do not support the idea that anxiety and depression are trivial, purely “mind over matter,” or best managed only with lifestyle changes in moderate to severe cases; instead they indicate that untreated moderate to severe anxiety and depression carry significant morbidity, impaired functioning, and long‑term health risks, and that evidence‑based psychotherapies and, when indicated, pharmacotherapies are necessary for optimal outcomes. [16][20] High‑quality sources also do not support the notion that a single supplement, breathing technique, or alternative therapy can reliably cure anxiety or depression in the general population; while meta-analyses show benefits of interventions like breathing exercises, gratitude practices, and saffron, these effects are modest, population‑specific, and insufficient to replace standard care. Guidelines explicitly caution against routine long‑term benzodiazepine use for anxiety and against antidepressant use in children with anxiety disorders, which contradicts any unqualified “medication for everyone” message; they also emphasize that antidepressants alone should not be the default first‑line treatment for most adults with moderate depression when psychological interventions are available. [13][15][18][19] Where evidence is weaker, systematic reviews highlight heterogeneity and methodological limitations in newer or more experimental approaches (such as some neurofeedback protocols or novel supplements), underscoring that these should be considered adjunctive or investigational rather than proven core treatments. In sum, if the influencer implies that anxiety and depression are either not real medical conditions or are reliably curable by a single non‑evidence‑based approach, that is not supported by current high-quality evidence.
- Mainstream view
- The mainstream medical and scientific position is that anxiety disorders and depressive disorders are common, serious, and heterogeneous mental health conditions with multifactorial causes, including biological, psychological, and social factors. [13][14][20] They are diagnosed using standardized criteria (such as DSM or ICD), often co-occur, and are associated with significant distress, functional impairment, and elevated risk of suicide and other adverse health outcomes. For generalized anxiety disorder, panic disorder, and major depressive disorder, major guidelines recommend structured psychological interventions—especially cognitive behavioral therapy, interpersonal therapy, and related modalities—as first-line treatments, particularly for mild to moderate presentations, and as essential components of care for more severe illness. [15][16][17][18] Pharmacotherapy with antidepressants, mainly SSRIs and SNRIs, is strongly evidence‑based and widely recommended for moderate to severe depression and functionally impairing anxiety, typically in combination with psychotherapy where feasible; continuation for at least several months after remission reduces relapse risk. Benzodiazepines are not considered first-line for chronic anxiety and are reserved for short-term management of acute severe anxiety, with careful tapering. For children and adolescents, drug treatment for anxiety and depression is more restricted, and guidelines emphasize psychological therapies as the primary modality. [19] Adjunctive interventions such as physical exercise, stress management, mindfulness-based therapies, breathing exercises, and collaborative care models are recognized as helpful additions, but they are Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Anxiety and depression”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmune conditions.
Autoimmune conditions
- Supports
- The only indexed paper directly relevant to the influencer’s very general claim about autoimmune conditions is the systematic review and meta-analysis on autoimmune disorders in oral lichen planus. [21] Those reviewer reports relate to a published meta-analysis showing comorbidity between oral lichen planus (OLP) and autoimmune thyroid disease and diabetes mellitus. This supports the more general concept that specific autoimmune conditions tend to cluster and co-occur in the same individual, because OLP patients show increased rates of other autoimmune diseases. [24] High‑quality recent reviews and background chapters from academic search further support that autoimmune diseases are a broad class of disorders characterized by immune responses directed against self-antigens, involving breakdown of immune tolerance and multifactorial genetic and environmental risk factors, consistent with standard immunology and rheumatology texts and NIH overviews. Large epidemiologic reviews and consensus articles also support that the overall prevalence of autoimmune diseases is rising globally, and that autoantibodies can precede clinical disease by years, again aligning with the general medical concept of autoimmune conditions as chronic, progressive illnesses. [23] Guidelines and major reviews further support that autoimmune diseases often share pathophysiologic mechanisms (e. g. , Th17 skewing, regulatory T‑cell dysfunction, inflammasome activation), and that many patients are at increased risk for additional autoimmune diseases or related complications such as cardiovascular disease and certain cancers. Overall, the indexed systematic review on OLP plus mainstream reviews from academic search support the broad notion that autoimmune conditions are real, biologically grounded entities, frequently comorbid, and associated with chronic morbidity.
- Contradicts
- The provided index papers are largely not directly about broad influencer‑style claims on autoimmune conditions; most are specific clinical trials (e. g. , DNA sequencing in practice, perioperative analgesia, platelet‑rich fibrin, cryptosporidiosis treatment) that do not address autoimmune pathogenesis, diagnosis, or treatment, and therefore cannot be used to substantiate sweeping claims about autoimmune conditions. [24] The reviewer reports for the oral lichen planus meta-analysis themselves highlight that, beyond autoimmune thyroid disease and type 1 diabetes, evidence linking OLP to other autoimmune disorders (fibromyalgia, rheumatic diseases, Sjögren’s, lupus, dermatologic diseases, gastrointestinal autoimmune disorders) is weak, inconsistent, or in need of better-quality studies, indicating limits to how far comorbidity claims can be generalized. [21][23] Broader academic reviews emphasize that although autoimmune diseases share certain immune mechanisms, they are heterogeneous conditions and not a single entity with a unified cause or simple cure; this contradicts common influencer narratives that treat “autoimmunity” as one monolithic syndrome that can be reversed with single lifestyle or supplement interventions. [22] Major reviews also note that, despite progress in targeted therapies and immunomodulatory approaches, many autoimmune diseases still lack curative treatments and require long-term management, again countering simplistic cure claims. Because the influencer’s actual claim is unspecified and only labeled as “Autoimmune conditions,” there is no high‑quality evidence in the indexed papers that would support any strong, nonstandard assertion (e. g. , that most chronic symptoms are unrecognized autoimmunity or that autoimmunity can generally be cured quickly).
- Mainstream view
- Mainstream medical and scientific consensus views autoimmune conditions as a diverse group of diseases in which the immune system mounts pathogenic responses against self-tissues, driven by a combination of genetic susceptibility, environmental triggers, and dysregulated immune tolerance. [24] Autoimmune diseases are defined and classified based on reproducible clinical criteria, characteristic autoantibodies or cellular immune findings, and often supported by animal models and mechanistic data. They are common, with increasing incidence and prevalence documented in large epidemiologic studies, and they frequently co-occur; patients with one autoimmune disease have a higher-than-expected risk of developing additional autoimmune disorders, as illustrated by the comorbidity between oral lichen planus and autoimmune thyroid disease and type 1 diabetes. [21][22][23] At the same time, mainstream medicine recognizes substantial heterogeneity: different autoimmune diseases affect distinct organs, have varied clinical courses (from mild to life‑threatening), and respond differently to treatments. Standard of care focuses on accurate diagnosis, risk stratification, and long‑term management using immunosuppressive and immunomodulatory therapies, biologics, and, increasingly, targeted molecular agents, aiming for disease Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Autoimmune conditions”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Mold and Lyme related illness as within their scope of practice.
Mold and Lyme related illness
- Supports
- The influencer claim appears to be that mold-related illness and Lyme-related illness are meaningfully linked or interact clinically. None of the user-provided index papers address mold–Lyme interactions; they focus on unrelated topics such as DNA sequencing, anesthetic regimens, mucosal healing, cryptosporidiosis treatment, employment after critical illness, and suicide methods. From broader academic and guideline literature (outside the index list), there is support for the idea that Lyme disease can coexist with other infections (tick‑borne coinfections like Babesia, Anaplasma, Ehrlichia, Bartonella), which can complicate clinical course and contribute to treatment failure. [25][26] There is also evidence that environmental mold exposure and mycotoxins can cause respiratory and allergic disease and, in some settings, systemic illness, and that both mycotoxins and chronic infections can affect the immune system and inflammatory pathways. This provides a biologically plausible basis for interactions in severely ill or immunocompromised patients, including those with Lyme disease, even though direct RCT-level evidence is lacking.
- Contradicts
- The index literature provided does not support any specific, strong causal claim that mold exposure is a common cause of Lyme disease, or that treating mold is a validated core component of evidence‑based Lyme management. High‑quality systematic reviews and guideline documents on Lyme disease emphasize tick‑borne bacteria and recognized coinfections, but they do not identify mold illness or mycotoxin exposure as established coinfections or standard treatment targets. A systematic review on chronic tick‑borne coinfections concluded that the medical literature does not support the diagnosis of chronic, atypical tick‑borne coinfections in patients with chronic nonspecific illnesses, highlighting that many proposed chronic co‑infection diagnoses lack robust evidence. By analogy, many of the strong claims in influencer and functional‑medicine circles that mold and Lyme "work together" to keep patients sick, that mold is a leading cause of persistent Lyme symptoms, or that specialized "mold detox" protocols are necessary, go beyond what controlled trials, major guidelines, or rigorous systematic reviews currently support. [26] Evidence specifically linking mold exposure to increased Lyme infection risk, failure of standard Lyme therapy, or a distinct combined syndrome with validated diagnostic criteria is weak and largely based on case series, expert opinion, and mechanistic speculation rather than high‑quality RCTs or meta‑analyses. [25]
- Mainstream view
- Mainstream infectious‑disease and environmental‑health positions are that Lyme disease is a tick‑borne bacterial infection caused primarily by Borrelia burgdorferi (and related species), sometimes accompanied by other tick‑borne coinfections (e. g. , Babesia, Anaplasma, Ehrlichia, Bartonella), and that diagnosis and treatment should follow established evidence‑based criteria. Mold and damp indoor environments are recognized causes of respiratory and allergic disease and can produce mycotoxins, which in some circumstances contribute to systemic illness, particularly in immunocompromised hosts, but mold illness is not currently considered a standard coinfection of Lyme disease nor a validated primary driver of typical post‑treatment Lyme symptoms in major guidelines. [25] The mainstream view is that it is possible for an individual to have both mold‑related illness and Lyme disease, and that overlapping nonspecific symptoms (fatigue, cognitive complaints, pain) can occur, but rigorous evidence showing that mold exposure commonly causes, sustains, or substantially modifies Lyme disease is limited. [26] Clinicians are encouraged to evaluate each condition with its own evidence‑based diagnostic framework rather than assuming a unified "mold–Lyme" syndrome in the absence of high‑quality supporting data.
“Mold and Lyme related illness”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure healing from CIRS.
healing from CIRS
No specific health claims of theirs were cross-checked against the literature.
“healing from CIRS”
Rule: K.S.A. 65-2912(a)(6)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS+.
CIRS+
No specific health claims of theirs were cross-checked against the literature.
“CIRS+”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The CIRS Brain Solution.
The CIRS Brain Solution
No specific health claims of theirs were cross-checked against the literature.
“The CIRS Brain Solution”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Blood sugar dysfunction.
Blood sugar dysfunction
- Supports
- The broad concept that blood sugar dysfunction (e. g. , impaired fasting glucose, insulin resistance, type 2 diabetes) is a real and clinically important condition is strongly supported by extensive epidemiologic and interventional research as well as major diabetes guidelines, which recognize abnormal glucose homeostasis as a key risk factor for microvascular and macrovascular disease. High‑quality evidence shows that certain dietary fibers and foods can modestly improve markers of blood sugar dysfunction (fasting glucose, HbA1c, HOMA‑IR) in adults with prediabetes or type 2 diabetes, supporting the idea that the condition is modifiable rather than fixed. [29] A GRADE‑assessed systematic review and meta‑analysis of 19 randomized controlled trials found that psyllium supplementation significantly reduced fasting blood sugar, HbA1c, and HOMA‑IR compared with placebo, indicating that dietary soluble fiber can improve glycemic control and insulin resistance in adults with elevated blood sugar. [30] Earlier meta‑analytic work on psyllium also showed that multi‑week dosing before meals improves fasting blood glucose and HbA1c in patients with type 2 diabetes, with greater effects in those with worse baseline control, reinforcing that blood sugar dysfunction responds to targeted interventions. Systematic reviews and meta‑analyses of flaxseed supplementation report statistically significant reductions in fasting blood sugar, insulin, HbA1c, and HOMA‑IR in populations with prediabetes and type 2 diabetes, further supporting the concept that abnormal glucose and insulin resistance are clinically tractable. [31][32] The existence of multiple recent grade‑assessed systematic reviews and meta‑analyses on foods, fibers, probiotics, and botanicals targeting fasting glucose, HbA1c, insulin, and HOMA‑IR underscores that blood sugar dysfunction is a well‑recognized clinical entity and an accepted therapeutic target in mainstream research and guidelines.
- Contradicts
- The influencer’s claim is extremely vague (“Blood sugar dysfunction”) and does not specify a mechanism, prevalence, or a particular nonstandard diagnostic category; mainstream evidence supports clinically defined dysglycemia but does not endorse broad, undefined notions of “blood sugar dysfunction” as a catch‑all explanation for diverse symptoms without appropriate testing. Although the psyllium meta‑analysis reports statistically significant improvements in fasting blood sugar, HbA1c, and HOMA‑IR, the average effect sizes are modest, and subgroup analyses show that lower doses and shorter durations may have non‑significant effects, indicating that changes in blood sugar dysfunction are not large or universal and depend on dose, duration, and baseline status. [29][30][31] Meta‑analyses of flaxseed show benefit on some glycemic markers but not consistently on HbA1c, and individual randomized trials in prediabetes have found no significant effects of flaxseed on fasting glucose, insulin, or HOMA‑IR, highlighting that specific dietary components are not reliable stand‑alone fixes for blood sugar dysfunction across all populations. [32] Because the claim as stated does not specify diagnostic criteria, magnitude of risk, or evidence‑based interventions, it conflicts with the more precise, guideline‑based approach that defines impaired fasting glucose, impaired glucose tolerance, and diabetes using standardized thresholds and treats them with individualized lifestyle and pharmacologic strategies.
- Mainstream view
- Mainstream medicine recognizes blood sugar dysfunction under specific diagnostic categories such as impaired fasting glucose, impaired glucose tolerance, prediabetes, and type 2 diabetes, defined by standardized thresholds for fasting plasma glucose, 2‑hour oral glucose tolerance test, and HbA1c set by organizations like the American Diabetes Association and WHO. [29][30] The prevailing view is that chronic dysglycemia and insulin resistance are common, multifactorial conditions driven by genetics, excess adiposity, physical inactivity, diet quality, and other factors, and they are major risk factors for cardiovascular disease, kidney disease, neuropathy, and retinopathy. Mainstream guidelines recommend structured lifestyle interventions (weight reduction, increased physical activity, dietary patterns high in whole grains and fiber and low in refined carbohydrates and added sugars) plus evidence‑based pharmacologic therapies (e. g. , metformin, GLP‑1 receptor agonists, SGLT2 inhibitors, insulin when needed) to prevent progression of blood sugar dysfunction and reduce complications. Foods and supplements like psyllium, flaxseed, and other high‑fiber or plant‑based interventions are viewed as potentially helpful adjuncts that can modestly improve fasting glucose, HbA1c, and insulin resistance in some patients Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [31][32]
“Blood sugar dysfunction”
Rule: K.S.A. 65-2912(a)(6)-(7)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Chronic inflammatory conditions.
Chronic inflammatory conditions
No specific health claims of theirs were cross-checked against the literature.
“Chronic inflammatory conditions”
Rule: K.S.A. 65-2912(a)(
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise I had the brain of a 70-year-old as within their scope of practice.
I had the brain of a 70-year-old
No specific health claims of theirs were cross-checked against the literature.
“the brain of a 70-year-old”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise even severe brain degeneration can be reversed as within their scope of practice.
even severe brain degeneration can be reversed
No specific health claims of theirs were cross-checked against the literature.
“even severe brain degeneration can be reversed”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure functional medicine.
functional medicine
No specific health claims of theirs were cross-checked against the literature.
“functional medicine”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Claims to manage blood sugar dysfunction, an endocrine/metabolic problem.
Claims to manage blood sugar dysfunction, an endocrine/metabolic problem
- Supports
- The broad concept that blood sugar dysfunction (e. g. , impaired fasting glucose, insulin resistance, type 2 diabetes) is a real and clinically important condition is strongly supported by extensive epidemiologic and interventional research as well as major diabetes guidelines, which recognize abnormal glucose homeostasis as a key risk factor for microvascular and macrovascular disease. High‑quality evidence shows that certain dietary fibers and foods can modestly improve markers of blood sugar dysfunction (fasting glucose, HbA1c, HOMA‑IR) in adults with prediabetes or type 2 diabetes, supporting the idea that the condition is modifiable rather than fixed. [29] A GRADE‑assessed systematic review and meta‑analysis of 19 randomized controlled trials found that psyllium supplementation significantly reduced fasting blood sugar, HbA1c, and HOMA‑IR compared with placebo, indicating that dietary soluble fiber can improve glycemic control and insulin resistance in adults with elevated blood sugar. [30] Earlier meta‑analytic work on psyllium also showed that multi‑week dosing before meals improves fasting blood glucose and HbA1c in patients with type 2 diabetes, with greater effects in those with worse baseline control, reinforcing that blood sugar dysfunction responds to targeted interventions. Systematic reviews and meta‑analyses of flaxseed supplementation report statistically significant reductions in fasting blood sugar, insulin, HbA1c, and HOMA‑IR in populations with prediabetes and type 2 diabetes, further supporting the concept that abnormal glucose and insulin resistance are clinically tractable. [31][32] The existence of multiple recent grade‑assessed systematic reviews and meta‑analyses on foods, fibers, probiotics, and botanicals targeting fasting glucose, HbA1c, insulin, and HOMA‑IR underscores that blood sugar dysfunction is a well‑recognized clinical entity and an accepted therapeutic target in mainstream research and guidelines.
- Contradicts
- The influencer’s claim is extremely vague (“Blood sugar dysfunction”) and does not specify a mechanism, prevalence, or a particular nonstandard diagnostic category; mainstream evidence supports clinically defined dysglycemia but does not endorse broad, undefined notions of “blood sugar dysfunction” as a catch‑all explanation for diverse symptoms without appropriate testing. Although the psyllium meta‑analysis reports statistically significant improvements in fasting blood sugar, HbA1c, and HOMA‑IR, the average effect sizes are modest, and subgroup analyses show that lower doses and shorter durations may have non‑significant effects, indicating that changes in blood sugar dysfunction are not large or universal and depend on dose, duration, and baseline status. [29][30][31] Meta‑analyses of flaxseed show benefit on some glycemic markers but not consistently on HbA1c, and individual randomized trials in prediabetes have found no significant effects of flaxseed on fasting glucose, insulin, or HOMA‑IR, highlighting that specific dietary components are not reliable stand‑alone fixes for blood sugar dysfunction across all populations. [32] Because the claim as stated does not specify diagnostic criteria, magnitude of risk, or evidence‑based interventions, it conflicts with the more precise, guideline‑based approach that defines impaired fasting glucose, impaired glucose tolerance, and diabetes using standardized thresholds and treats them with individualized lifestyle and pharmacologic strategies.
- Mainstream view
- Mainstream medicine recognizes blood sugar dysfunction under specific diagnostic categories such as impaired fasting glucose, impaired glucose tolerance, prediabetes, and type 2 diabetes, defined by standardized thresholds for fasting plasma glucose, 2‑hour oral glucose tolerance test, and HbA1c set by organizations like the American Diabetes Association and WHO. [29][30] The prevailing view is that chronic dysglycemia and insulin resistance are common, multifactorial conditions driven by genetics, excess adiposity, physical inactivity, diet quality, and other factors, and they are major risk factors for cardiovascular disease, kidney disease, neuropathy, and retinopathy. Mainstream guidelines recommend structured lifestyle interventions (weight reduction, increased physical activity, dietary patterns high in whole grains and fiber and low in refined carbohydrates and added sugars) plus evidence‑based pharmacologic therapies (e. g. , metformin, GLP‑1 receptor agonists, SGLT2 inhibitors, insulin when needed) to prevent progression of blood sugar dysfunction and reduce complications. Foods and supplements like psyllium, flaxseed, and other high‑fiber or plant‑based interventions are viewed as potentially helpful adjuncts that can modestly improve fasting glucose, HbA1c, and insulin resistance in some patients Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [31][32]
“Blood sugar dysfunction”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Claims functional medicine diagnosis of root causes for chronic disease.
Claims functional medicine diagnosis of root causes for chronic disease
No specific health claims of theirs were cross-checked against the literature.
“functional medicine”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Functional medicine root-cause programs for chronic disease as within their scope of practice.
Functional medicine root-cause programs for chronic disease
No specific health claims of theirs were cross-checked against the literature.
“functional medicine”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Jonah Dallas Yakel is not approved to offer Detoxification protocols within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).
Detoxification protocols
No specific health claims of theirs were cross-checked against the literature.
“environmental remediation to detoxification protocols, brain repair, and lifestyle modifications”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
transcript · cited
He frames a terrifying prognosis to create urgency and make his later healing protocol feel lifesaving, even though the underlying claim about reversing severe degeneration is not established by mainstream evidence. Likely motive: Drive fear, then convert it into consults and program sales.
“I would be lucky to know my wife and kids within five years”
transcript · cited
He presents as 'Dr.' while discussing neurodegeneration, autoimmune disease, Lyme, blood sugar dysfunction, and CIRS—topics far beyond routine chiropractic scope. Likely motive: Leverage the prestige of a doctor title to appear qualified in internal medicine.
“Dr. Jonah Yakel is a chiropractor and functional health practitioner who consults with people around the world”
transcript · cited
Invoking a niche authority without showing broad consensus lets him cherry-pick a contested mold/CIRS narrative as if it were settled medicine. Likely motive: Make a controversial protocol sound established and specialized.
“Working with Dr. Ritchie Shoemaker, a pioneer in mold-related illness”
source material
He uses his own recovery story plus unnamed client success as substitute evidence. That is classic testimonial stacking: emotionally compelling, but not the same as controlled evidence. Likely motive: Turn anecdote into authority and sell a repeatable healing framework.
transcript · cited
This is a direct invitation into a paid advisory relationship for chronic disease claims, including conditions outside chiropractic scope. Likely motive: Convert fear around chronic illness into paid 1:1 consults.
“I consult with people worldwide”
Commerce & grift map
The funnel is classic: scary chronic-illness framing, a pseudo-broad diagnostic identity, then personalized programs and detox-style interventions that can be sold in 1:1 consults. The money likely flows from fear into coaching time, supplement recommendations, and repeat follow-up rather than from any evidence-based disease-management pathway.
No FTC-style compensation disclosure
compensationDisclosures · scan
Paid 1:1 consults for chronic disease and brain health claims
coaching_program
Supplements pitched
- supplementation
“diet, exercise, sleep, supplementation, and detoxification”
- detoxification protocols
“detoxification protocols”
How the money flows
- Coaching or consult upsellUndisclosed Paid 1:1 consults for chronic disease and brain health claims “I consult with people worldwide”
“I consult with people worldwide”
- Other financial tieUndisclosed Functional medicine / personalized health programs for chronic disease “creating personalized health programs for a wide range of conditions”
“creating personalized health programs for a wide range of conditions”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- supplementationBrand
Named on a surface without a compensation disclosure
- detoxification protocolsBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · KS license 0105307.
Jonah Yakel appears to hold a chiropractic license and uses the 'Dr.' title to project general medical authority. The problem is not the title itself; it is the leap from spinal/musculoskeletal practice into brain MRI interpretation, neurodegeneration, autoimmune disease, Lyme, blood sugar disorders, and CIRS treatment as if chiropractic were a general internal-medicine credential.
- DC, Doctor of Chiropractic
A state-licensed chiropractic degree that can use 'doctor' in some settings, but it is not an MD/DO physician license.
State chiropractic boards generally limit practice to musculoskeletal/spinal care and authorized adjunctive therapies, not diagnosing or treating systemic internal disease, dementia, autoimmune disease, Lyme, endocrine disorders, or detox protocols.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: medium
Kansas chiropractors are authorized to examine, diagnose, and treat patients by chiropractic methods focused on the spine and musculoskeletal/neuromusculoskeletal system; they are not granted authority to practice medicine or manage systemic internal diseases. The Board expects non‑physician licensees to limit care to what is affirmatively authorized and to refer patients when conditions fall outside their scope of knowledge or practice.[3] Violations can constitute unprofessional conduct and grounds for discipline.[3]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
22 of 24 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Cognitive decline, dementia, and Alzheimer's disease Rule: K.S.A. 65-2912(a)(6)-(7) (analogous scope/discipline limits for non‑physician providers) Diagnosing cognitive decline, dementia, and Alzheimer’s disease constitutes diagnosis of complex neurodegenerative medical conditions, which are not affirmatively authorized for chiropractors and fall outside chiropractic’s musculoskeletal focus.[3] | Outside scope |
| Listed service Anxiety and depression Rule: K.S.A. 65-2912(a)(6)-(7) Diagnosing or managing anxiety and depression is mental health/psychiatric practice, not affirmatively granted in chiropractic statutes and beyond a chiropractor’s authorized musculoskeletal scope.[3] | Outside scope |
| Listed service Autoimmune conditions Rule: K.S.A. 65-2912(a)(6)-(7) Diagnosing or managing autoimmune diseases involves internal medicine and systemic immunologic disorders, which are not affirmatively included in chiropractic scope in Kansas. | Outside scope |
| Listed service Mold and Lyme related illness Rule: K.S.A. 65-2912(a)(6)-(7) Diagnosing and managing systemic illness attributed to mold exposure or Lyme disease is infectious/internal medicine care, not affirmatively permitted to chiropractors in Kansas. | Outside scope |
| healing from CIRS Rule: K.S.A. 65-2912(a)(6) Offering to heal from chronic inflammatory response syndrome (CIRS) implies treatment of a systemic, contested internal illness model beyond the musculoskeletal focus affirmatively granted to chiropractors. | Outside scope |
| Listed service CIRS+ Rule: K.S.A. 65-2912(a)(6)-(7) Branding or marketing a CIRS+ program implies structured management of systemic inflammatory illness, an internal medical role not affirmatively authorized for Kansas chiropractors. | Outside scope |
| Listed service The CIRS Brain Solution Rule: K.S.A. 65-2912(a)(6)-(7) A named program to treat CIRS-related brain dysfunction goes beyond neuromusculoskeletal chiropractic care into systemic disease and neurodegenerative treatment not authorized by statute. | Outside scope |
| Claims to treat neurodegenerative disease and dementia/Alzheimer's beyond chiropractic scope Rule: K.S.A. 65-2912(a)(6) Treating neurodegenerative diseases such as dementia and Alzheimer’s represents medical management of complex brain disease, which is not affirmatively described in Kansas chiropractic authorization. | Outside scope |
| Claims to manage autoimmune disease, an internal medical condition Rule: K.S.A. 65-2912(a)(6)-(7) Managing autoimmune disease is internal medicine care and the Kansas framework only authorizes chiropractors for chiropractic, not broad medical management of systemic disorders.[3] | Outside scope |
| Claims to diagnose/treat Lyme and mold-related systemic illness Rule: K.S.A. 65-2912(a)(6)-(7) Diagnosis and treatment of Lyme disease and systemic mold illness are infectious disease/internal medicine functions not affirmatively included in the chiropractic scope in Kansas. | Outside scope |
| Claims to heal from CIRS, a contested systemic illness model Rule: K.S.A. 65-2912(a)(6) Claiming to heal CIRS constitutes treatment of a systemic, non‑musculoskeletal disease model that Kansas law does not affirmatively permit for chiropractors. | Outside scope |
| CIRS and mold-related illness healing protocols Rule: K.S.A. 65-2912(a)(6)-(7) Developing healing protocols for CIRS and mold-related illness is systemic disease management outside the limited chiropractic scope focused on neuromusculoskeletal care. | Outside scope |
| Listed service Blood sugar dysfunction Rule: K.S.A. 65-2912(a)(6)-(7) Diagnosing blood sugar dysfunction, including prediabetes or diabetes, involves endocrine/metabolic medicine and is not affirmatively granted to chiropractors under Kansas law. | Outside scope |
| Listed service Chronic inflammatory conditions Rule: K.S.A. 65-2912(a)( Diagnosing and broadly managing chronic inflammatory systemic conditions goes beyond neuromusculoskeletal chiropractic practice into internal medicine, which Kansas does not authorize for chiropractors. | Outside scope |
| I had the brain of a 70-year-old Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| even severe brain degeneration can be reversed Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service functional medicine Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Claims to manage blood sugar dysfunction, an endocrine/metabolic problem Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Claims functional medicine diagnosis of root causes for chronic disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Functional medicine root-cause programs for chronic disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Detoxification protocols Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Brain repair / reversal of severe degeneration Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Kansas State Board of Healing Arts – Agency site (official), Kansas Statutes – scope and discipline language (example for non‑physician providers) (official), Kansas State Board of Healing Arts – profession information (chiropractic), 1987-042 | 3/5/1987 | Kansas Attorney General Opinion | Robert T. Stephan / Rita L. Noll
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near OVERLAND PARK, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-22 05:18 UTC. The archive pane loads styles and images from the intake snapshot.
9 licensed-care paths linked for out-of-scope claims.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drjonahyakel.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission nq9ARZIGLmTPy1JqUOWz9
Fight disinformation
Log a public thread where Jonah Dallas Yakel is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Jonah Dallas Yakel's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/nq9ARZIGLmTPy1JqUOWz9. White-coat charisma isn't evidence.
Full DTMB scan on Jonah Dallas Yakel: https://drtrustmebro.com/analyze/nq9ARZIGLmTPy1JqUOWz9
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We email a public contact address from their site so Jonah Dallas Yakel can review this dossier and dispute anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Jonah Dallas Yakel, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Jonah Dallas Yakel. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: 0o8IxZAbZXTO291VUoiW9
- Wall entry: /influencer/0o8IxZAbZXTO291VUoiW9
- Analysis ID: nq9ARZIGLmTPy1JqUOWz9
- Source: https://www.drjonahyakel.com
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Effect of diabetes medications on the risk of developing ...
- [2] Adult Renal Dysfunction and Risk of Dementia or Cognitive ...
- [3] Diabetes, antidiabetic medications and risk of dementia
- [4] Multi-Domain Interventions for Dementia Prevention
- [5] PubMed indexed study
- [6] PubMed indexed study
- [7] PubMed indexed study
- [8] PubMed indexed study
- [9] PubMed indexed study
- [10] PubMed indexed study
- [11] PubMed indexed study
- [12] PubMed indexed study
- [13] Treatment of anxiety disorders - PMC - NIH
- [14] WHO issues new and updated recommendations on ...
- [15] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
- [16] WHO Guidelines
- [17] Management of generalized anxiety disorder and panic ... - PMC
- [18] Management of first depression or generalized anxiety disorder episode in adults in primary care: A systematic metareview - PubMed
- [19] Summary of the clinical practice guideline for the treatment ...
- [20] A systematic review of EEG neurofeedback in fibromyalgia to treat psychological variables, chronic pain and general health
- [21] Autoimmune disorders in oral lichen planus: A systematic review and ...
- [22] One year in autoimmunity - PubMed
- [23] The Increasing Prevalence of Autoimmunity and ... - PMC
- [24] Autoimmune Diseases: Molecular Pathogenesis and ... - PMC
- [25] A50-06 A Case of Coinfection of Babesiosis and Lyme Disease in a Patient With No Risk Factors or Exposure
- [26] Notes from the Field: Reference Laboratory Investigation of Patients with Clinically Diagnosed Lyme Disease and Babesiosis — Indiana, 2016
- [27] PubMed indexed study
- [28] PubMed indexed study
- [29] The effect of psyllium on fasting blood sugar, HbA1c, HOMA IR ...
- [30] The effect of psyllium on fasting blood sugar, HbA1C, HOMA IR, and insulin control: systematic review and dose-response meta-analysis of randomized controlled trials
- [31] Effect of flaxseed (Linum usitatissimum) supplementation ...
- [32] Flaxseed supplementation on glucose control and insulin ...